What is the most likely diagnosis and recommended workup and management for a 2.9 × 1.7 cm lesion in the distal femoral metaphysis with mixed signal intensity, arc‑and‑ring appearance, and circumscribed sclerotic borders?

Most Likely Diagnosis: Chondroid Lesion (Enchondroma vs. Low-Grade Chondrosarcoma)

The imaging features described—a 2.9 × 1.7 cm lesion in the distal femoral metaphysis with mixed signal intensity, arc-and-ring appearance, and circumscribed sclerotic borders—are classic for a cartilaginous tumor, most likely an enchondroma, though low-grade chondrosarcoma must be excluded through tissue diagnosis.

Differential Diagnosis

The "arc-and-ring" appearance with mixed signal intensity represents chondroid matrix mineralization, which is pathognomonic for cartilaginous lesions. The key differentials include:

Primary Consideration: Enchondroma

• Location: Distal femoral metaphysis is a common site for enchondromas 1
• Imaging characteristics: The circumscribed sclerotic borders and geographic appearance favor a benign process
• Size consideration: At 2.9 cm, this falls within the typical size range for enchondromas (mean 2.7 cm in epiphyseal series) 1

Critical Alternative: Low-Grade Chondrosarcoma

• Diagnostic challenge: These lesions have significant overlap with enchondromas in clinical presentation, imaging, and even histopathology 2
• Size threshold: Lesions >3 cm raise concern for malignancy, though this lesion is just below that threshold
• Location: The distal femur is also a common site for chondrosarcoma

Less Likely Considerations:

• Chondroblastoma: Typically epiphyseal rather than metaphyseal, more common in younger patients 3
• Parosteal osteosarcoma: Surface-based lesion, most common on posterior distal femur, but lacks the characteristic chondroid matrix pattern 4, 5

Recommended Workup Algorithm

Step 1: Complete Imaging Evaluation

• Plain radiographs (AP and lateral): Assess for matrix mineralization pattern, cortical integrity, periosteal reaction
• MRI with contrast: Already obtained; evaluate for:
  • Soft tissue extension
  • Cortical breakthrough
  • Periosteal reaction
  • Endosteal scalloping >2/3 cortical thickness (suggests malignancy)
• CT scan: Better characterizes matrix mineralization and cortical involvement

Step 2: Clinical Correlation

• Pain assessment: Persistent, progressive pain favors malignancy; enchondromas are often asymptomatic or cause mild intermittent pain 1
• Patient age: Younger patients (10-40 years) more likely enchondroma; older patients increase chondrosarcoma risk
• Growth pattern: Documented enlargement on serial imaging suggests malignancy

Step 3: Tissue Diagnosis

Biopsy is mandatory to differentiate enchondroma from low-grade chondrosarcoma 2. The critical caveat: initial biopsies can be inconclusive or discordant.

• CT-guided core needle biopsy: First-line approach
• If inconclusive: Repeat biopsy after multidisciplinary tumor board review 2
• Consider open biopsy: If two core biopsies remain non-diagnostic

Step 4: Staging (if malignancy suspected)

• Chest CT: Rule out pulmonary metastases (most common site for bone sarcoma metastases) 4
• PET-CT: May help differentiate benign from malignant cartilaginous lesions 2
• Whole bone imaging: Assess for skip lesions 4

Management Recommendations

If Enchondroma Confirmed:

Intralesional curettage with bone cement or bone graft filling is the treatment of choice 2, 1.

• Indications for surgery:

  • Symptomatic lesions with persistent pain
  • Lesions causing mechanical symptoms
  • Proximity to joint space 1
  • Patient anxiety despite benign diagnosis

• Surgical technique: Extended curettage with adjuvants (phenol, liquid nitrogen, or cement) reduces recurrence risk

• Expected outcomes: Low recurrence rate (1/26 in one series) 1

• Observation option: Asymptomatic, definitively benign lesions can be monitored with serial radiographs

If Low-Grade Chondrosarcoma Confirmed:

Wide surgical excision with negative margins is the definitive treatment—chemotherapy and radiation are generally ineffective for chondrosarcoma.

• Surgical approach: En bloc resection with limb salvage reconstruction
• Margin assessment: Histologically negative margins are the most critical prognostic factor 4
• Follow-up: Long-term surveillance for local recurrence and late metastases

Critical Pitfalls to Avoid

1. Assuming benignity without tissue diagnosis: The imaging overlap between enchondroma and low-grade chondrosarcoma is substantial 2

2. Accepting a single inconclusive biopsy: Repeat biopsy after multidisciplinary review is essential when initial results are equivocal 2

3. Inadequate surgical margins if malignant: Intralesional procedures for chondrosarcoma lead to high recurrence rates and potential for dedifferentiation

4. Overlooking clinical-radiological discordance: Pain out of proportion to imaging findings should raise suspicion for malignancy

5. Delayed workup in symptomatic patients: Progressive symptoms warrant expedited evaluation, as osteosarcoma symptoms are often initially attributed to growing pains or trauma 4

Algorithmic Decision Framework

Symptomatic + Aggressive Features (pain, size >3cm, cortical destruction) → Urgent biopsy → If malignant: staging + wide excision

Asymptomatic + Benign Features (small, sclerotic border, no cortical breach) → Biopsy → If benign: observation vs. curettage based on symptoms

Equivocal Features → Biopsy → If inconclusive: repeat biopsy + tumor board → Definitive diagnosis → Appropriate treatment

The presence of circumscribed sclerotic borders and the geographic nature favor enchondroma, but tissue diagnosis remains non-negotiable given the potential for low-grade chondrosarcoma and the dramatically different treatment implications for patient morbidity and mortality.